Navigation Links
ARIUS announces second quarter fiscal 2008 financial results
Date:7/11/2008

$

-------------------------------------------------------------------------

Revenue:

Research contract 262,478 - 1,996,120

Product 60,675 21,392 280,049

Licensing fees 101,000 - 3,385,703

Research grant payments - - 273,663

-----------------------------------------------------------------------

424,153 21,392 5,935,535

Expenses:

Research and development,

net of tax credits 3,337,461 2,102,603 31,331,946

General and administrative 1,149,402 762,673 13,168,494

Foreign exchange loss (gain) (236,020) 319,481 508,201

Interest expense 551 771 906,768

-----------------------------------------------------------------------

4,251,394 3,185,528 45,915,409

-----------------------------------------------------------------------

Loss before the undernoted (3,827,241) (3,164,136) (39,979,874)

Interest income 69,720 181,484 2,221,804

Loss on extinguishment of debt - - (782,143)

-------------------------------------------------------------------------

Loss before income taxes (3,757,521) (2,982,652) (38,540,213)

Income taxes:

Current (59,416) (53,480) (394,438)

-------------------------------------------------------------------------

Loss and comprehensive loss

for the period (3,816,937) (3,036,132) (38,934,651)

Deficit, beginning of period (35,117,714) (23,783,289) -

---------------------------------
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ARIUS presents new findings for anti-cancer antibody programs at AACR
2. ARIUS announces first quarter fiscal 2008 financial results
3. ARIUS 2008 Annual and Special Meeting of Shareholders
4. ARIUS recognized for entrepreneurial excellence
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
7. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
8. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
9. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... According to Jeff Howell, Partner of ... Global, new development in Downtown Toronto is expanding at ... another 755 storeys of new development last week (including ... be dominating the Toronto skyline for the foreseeable future ... thirst for new development. , As the Toronto city ...
(Date:9/15/2014)... , Sept. 15, 2014 ... on revolutionizing the treatment of cancer through the ... cells, announced that, together with the Asbestos Disease ... Cancer Institute New South Wales (NSW) Premier,s Award ... four recipients are the hospitals that will be ...
(Date:9/15/2014)... led by Northeastern University has developed a novel ... a variety of nanocarbon structures in carbon nanotube ... which will allow the researchers to tailor the ... applications ranging from electronic devices to CNT-reinforced composite ... equipment. , Their findings were published in the ...
(Date:9/15/2014)... AUSTIN, Texas , Sept. 15, 2014 The ... changes in climate, says a new article published by the ... Ahmed , PhD, on climate change and its effects on ... part of an extensive study conducted by Dr. Ahmed in ... China and has implications for the future ...
Breaking Biology Technology:ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 2EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 3Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4
... -- Aurora Health Care is planning to open a ... new digital hospital will include the latest in digital ... physicians will benefit from enterprise storage and distribution of ... , ,Aurora Health Care established in 1984 is ...
... Growth Council seems like a well-intentioned group, but Im concerned ... of council members, I was astonished that only three women ... , ,So I set-off on a fact-finding mission and found ... the U.S. are started by women, Gen Xers (b. 1961-1981), ...
... Wis.In a business world where even very specialized services and ... staying one step ahead of the rat race. , ,The ... processing chips for high-end networking and computing customers such as ... name a few. , ,WTN sat down with Jeff ...
Cached Biology Technology:Aurora Selects New Imaging Technology 2Silicon Logic Engineering Ramps Up Custom Chips 2Silicon Logic Engineering Ramps Up Custom Chips 3Silicon Logic Engineering Ramps Up Custom Chips 4
(Date:9/16/2014)... than $100 trillion in cumulative public and private ... (CO2)a 40 percent reduction of urban passenger transport ... expands public transportation, walking and cycling in cities, ... University of California, Davis, and the Institute for ... an estimated 1.4 million early deaths could be ...
(Date:9/16/2014)... has its own bacterial identity. That,s the conclusion of ... who studied the genetic fingerprints of bacteria on 57 ... "This study demonstrates for the first time that host ... strategies possess very different microbial communities on their leaves," ... researcher in the UO,s Institute of Ecology and Evolution ...
(Date:9/16/2014)... XL pipeline (KXL) would likely increase oil sands extraction, ... by the non-profit organization Near Zero. The results are ... and includes both supporters and opponents of the pipeline. ... could lead to significantly higher greenhouse gas emissions, with ... , "This report examines three main scenarios discussed ...
Breaking Biology News(10 mins):Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 2Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 4Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 5Microbiome research shows each tree species has a unique bacterial identity 2Keystone XL would likely raise oil sands production and greenhouse gas emissions 2
... at Johns Hopkins report using a laser beam to activate ... act like a school of fish turning in social unison, ... The study of this unexpected cell movement, reported ... importance for understanding embryonic development, wound healing and tumor metastasis ...
... In the year since their 2008 preliminary ranking, Cell Press journals ... saw their Impact Factors surge, according to new data released ... the report released June 17, Cell Stem Cell ,s rating ... previous score. Cell Host and Microbe ranks 13.021 - ...
... tropical diseases, left aside by big pharma and governments alike, ... more attention has to be paid to early diagnosis and ... Organization urgently need to be changed. So say scientists of ... years of research in Congo. The disease is caused ...
Cached Biology News:Fly cells flock together, follow the light 2Fly cells flock together, follow the light 3New 2009 Impact Factors soar for newest Cell Press journals 2WHO guidelines on Buruli ulcer need adjustment 2
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
... in heart tissues, and is produced ... conditions. Treatment of cells with ... TIMP-4 in some cell types, but ... require concentration of cell culture media ...
Mouse monoclonal [002-49] to C1s ( Abpromise for all tested applications). entrezGeneID: 716 SwissProtID: P09871...
Biology Products: